July 29, 2019July 29, 2019

CHMP Favors Approving Stelara to Treat Moderate to Severe Ulcerative Colitis in EU

News

The Committee for Medicinal Products for Human Use (CHMP), part of the European Medicines Agency (EMA), has recommended that Stelara (ustekinumab) be approved in Europe to treat moderately to severely active ... Read more

December 20, 2017

Alofisel for Crohn’s Fistulas Receives EMA Recommendation for Marketing Authorization in EU

News

TiGenix received a European Medicines Agency (EMA) recommendation for the marketing authorization of Alofisel (darvadstrocel, Cx601) as an advanced therapy medicinal product (ATMP) for the treatment of complex perianal fistulas in people with ... Read more